FINWIRES · TerminalLIVE
FINWIRES

Kehua Bio-Engineering's Unit Gets Registration Certificate for Metapneumovirus Nucleic Acid Kit

By

Shanghai Kehua Bio-Engineering's (SHE:002022) unit, Suzhou Tianlong Biotechnology, received a medical device registration certificate from China's National Medical Products Administration for a swab kit for metapneumovirus nucleic acid, according to a Shenzhen bourse filing on Thursday.

The certificate for the human metapneumovirus nucleic acid detection kit is valid until May 10, 2031.

The Chinese in vitro diagnostics company's shares fell 2% during the afternoon trade.

Related Articles